Utility of diagnosing H. pylori in presence of intestinal metaplasia

Kaynakça (1)

1. Polymnia Galiatsatos, Jonathan Wyse, Andrew Szilagyi. Accuracy of biopsies for Helicobacter pylori in the presence of intestinal metaplasia of the stomach. Turk J Gastroenterol 2014; 25: 19-23. [CrossRef] 2. Malfertheiner P, Megraud F, O'Morain CA, et al. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-64. [CrossRef] 3. Mera R, Fontham ET, Bravo LE, et al. Long term follow up of patients treated for Helicobacter pylori infection. Gut 2005; 54: 1536-40. [CrossRef] 4. Take S, Mizuno M, Ishiki K, et al. The effect of eradicating helicobacter pylori on the development of gastric cancer in patients with peptic vulcer disease. Am J Gastroenterol 2005; 100: 1037-42. [CrossRef] 5. Fuccio L, Zagari RM, Eusebi LH, et al. Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med 2009; 151: 121-8. [CrossRef] 6. Nozaki K, Shimizu N, Ikehara Y, et al. Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 2003; 94: 235-9. [CrossRef] 7. Courillon-Mallet A. Follow-up of patients after Helicobacter pylori eradication. Rev Prat 2014; 64: 211-4. 8. Kwak HW, Choi IJ, Cho SJ, et al. Characteristics of gastric cancer according to Helicobacter pylori infection status. J Gastroenterol Hepatol 2014 Apr 14. doi: 10.1111/jgh.12605. [Epub ahead of print] [CrossRef] 9. Gisbert JP. Helicobacter pylori-related diseases. Gastroenterol Hepatol 2013; 36 (Suppl 2): S39-50. doi: 10.1016/S0210- 5705(13)70052-9. [Epub ahead of print] [CrossRef] 10. Yoon H, Kim N, Lee HS, et al. Helicobacter pylori-negative gastric cancer in South Korea: incidence and clinicopathologic characteristics. Helicobacter 2011; 16: 382-8. [CrossRef]